Participants' Response to the Discontinuation of 2% PRO2000/5 Microbicide Gel
Author Information
Author(s): Gafos Mitzy, Mzimela Misiwe, Ndlovu Hlengiwe, Mhlongo Nkosinathi, Hoogland Yael, Mutemwa Richard
Primary Institution: Africa Centre for Health and Population Studies, University of KwaZulu-Natal
Hypothesis
How do participants respond to the discontinuation of a microbicide gel in a clinical trial?
Conclusion
Participants initially feared harm from the discontinuation of the gel but eventually accepted the decision after effective communication.
Supporting Evidence
- Participants initially feared that the discontinuation was due to harm.
- Effective messaging helped participants accept the discontinuation.
- Many participants expressed disappointment over losing access to the gel.
- Qualitative methods allowed for real-time adjustments to communication strategies.
- Retention rates showed that 78% of discontinued participants completed follow-up visits.
Takeaway
When a gel that was supposed to help prevent HIV was stopped, many women were scared at first but learned it was for a good reason and accepted it over time.
Methodology
Qualitative methods including ethnographic participant observation, in-depth interviews, and focus group discussions were used to gather data.
Potential Biases
Potential bias in participant responses due to fear of stigma and misunderstanding of the trial's purpose.
Limitations
Findings are based on responses from one of six research centers, which may not represent other settings.
Participant Demographics
Participants were women aged 19 to 64, primarily from a rural area in KwaZulu-Natal, South Africa.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website